This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its structure is particularly valuable in the development of compounds targeting the central nervous system, where it can be incorporated into molecules designed to treat anxiety, insomnia, and other neurological disorders. Additionally, its benzodiazepine-like framework makes it a potential candidate for research into anticonvulsant and muscle relaxant medications. Its hydrochloride form enhances solubility, making it more suitable for formulation into injectable or oral dosage forms. Researchers also explore its derivatives for potential applications in treating mood disorders due to its interaction with neurotransmitter receptors in the brain.